2021-03-27 · March 11 (Reuters) - Protara Therapeutics Inc ::PROTARA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND BUSINESS OVERVIEW.Q4 LOSS PER SHARE $0.79.CASH
2020-05-14 · PROTARA THERAPEUTICS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Protara Therapeutics Inc Registered Shs | A2P4JE | TARA | US74365U1079
Protara Therapeutics | 1,037 followers on LinkedIn. Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies 2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases.
Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought. NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) --ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately.As part of the name change, the Company has launched a new corporate website, … 2020-10-02 Protara Therapeutics develops transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy created for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … See the company profile for Protara Therapeutics, Inc. (TARA) including business summary, industry/sector information, number of employees, business … Jesse Shefferman is President/CEO at Protara Therapeutic Inc. See Jesse Shefferman's compensation, career history, education, & memberships. Protara Therapeutics, Inc. operates as a biotech company. The Company develops various types of treatments for rare and specialty diseases.
Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies
Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. 2021-03-11 Protara Therapeutics Inc (TARA:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Protara Therapeutics Inc (TARA:NMQ) financials, including income statements, growth rates, balance sheets and cash flow information. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company.
Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Address:Protara Therapeutics, Inc.345 Park Avenue South3rd FloorNew York, NY 10010Phone:+1 646-844-0337Email:info@protaratx.comFollow us on Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com The average salary for IT Outsourcing Management - Career at companies like PROTARA THERAPEUTICS, INC. in the United States is $119,100 as of March 29, 2021, but the salary range typically falls between $106,800 and $133,500.
Compare pay for popular roles and read about the team’s work-life balance. Uncover why Protara Therapeutics, Inc. is the best company for you. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers
The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, we believe only by reflecting the world in which we live can we truly understand and treat cancer and rare diseases with significant unmet needs which often know no boundaries of age, gender, race, religion or
Dr. Julio Casoy has served as Protara’s Chief Medical Officer since February 2019 and brings over 35 years of experience in both development and commercialization expertise to Protara.
Toast bellmansro
Contact · Careers · Market Hours · Glossary. © 2020 OTC Markets Group Inc. Terms of Service Linking Protara Therapeutics, Inc. Company Intro. Steadfast and tenacious in our search for transformative therapies TARA-002 for Lymphatic Malformations TARA-002 is See charts, data and financials for Protara Therapeutics Inc TARA. Budgeting · Banking and Credit · Taxes · Family Finance · Debt · Careers. BACK; Careers Stock quote and company snapshot for PROTARA THERAPEUTICS INC (TARA), including profile, stock chart, recent news and events, analyst opinions, and Latest Protara Therapeutics Inc (1KPA:BER) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders.
Stoppa nysning
crm program
föräldralösa barn i världen
importera bil från dubai
postnord kundtjanst nummer
studentbostäder linköping
2021-03-11 · NEW YORK (AP) _ Protara Therapeutics, Inc. (TARA) on Thursday reported a loss of $8.8 million in its fourth quarter. The New York-based company said it had a loss of 79 cents per share. For the
Dr. Flannelly, who currently serves as Executive Vice President, General Manager, North America, at Incyte, brings to Protara over 20 years of commercial and business development leadership experience across numerous leading pharmaceutical and biotech companies. 2021-03-11 Nov. 12, 2020 -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Protara Therapeutics against related stocks people have also bought. NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) --ArTara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company identifying and advancing transformative therapies for people with rare and specialty diseases, today announced that it has changed its name to Protara Therapeutics, Inc., effective immediately.As part of the name change, the Company has launched a new corporate website, … 2020-10-02 Protara Therapeutics develops transformative therapies for people with cancer and rare diseases.
Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. Business Areas: Small Molecules, Rare Diseases Protara Therapeutics | Biotech Careers
© 2020 OTC Markets Group Inc. Terms of Service Linking Protara Therapeutics, Inc. Company Intro. Steadfast and tenacious in our search for transformative therapies TARA-002 for Lymphatic Malformations TARA-002 is See charts, data and financials for Protara Therapeutics Inc TARA. Budgeting · Banking and Credit · Taxes · Family Finance · Debt · Careers.
Executive Director, Strategy and Business Development at Protara Therapeutics Career Infinite升涯求职 - Business Development Representative. Nevada for $18.5 Million · Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview. Nevada for $18.5 Million · Protara Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Business Overview. Pharmaceuticals Corp (Aktieinformation). Aktieinformation Zomedica Pharmaceuticals Corp Resultaten Zomedica Pharmaceuticals Corp · Grafiek Zomedica CAREERS At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics | 766 followers on LinkedIn | Steadfast and tenacious in our search for transformative therapies | Protara is committed to identifying and advancing transformative therapies Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases.